bioAffinity Technologies, Inc. Common Stock
Symbol: BIAF (NASDAQ)
0.26
▲ (3.23%) 0.008
Company Description:
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
Key Stats
- Today's Open: $0.241
- Today's High: $0.269
- Today's Low: $0.226
- Today's Volume: 851.43K
- Yesterday Close: $0.248
- Yesterday High: $0.2534
- Yesterday Low: $0.2355
- Yesterday Volume: 542.25K
- Last Min Volume: 3
- Last Min High: $0.256
- Last Min Low: $0.256
- Last Min VWAP: $0.256
Company Profile
- Name: bioAffinity Technologies, Inc. Common Stock
- Website: https://www.bioaffinitytech.com
- Listed Date: 2022-09-01
- Location: SAN ANTONIO, TX
- Market Status: Active
- CIK Number: 0001712762
- SIC Code: 8731
- SIC description: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Market Cap: $7.24M
- Round Lot: 100
- Outstanding Shares: 29.57M
- Asset Type: CS
RECENT FILINGS FOR BIAF
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 8-K | View |
| 2025-09-05 | 8-K | View |
| 2025-09-03 | 8-K | View |
| 2025-09-02 | 8-K | View |
| 2025-08-29 | S-1 | View |
| 2025-08-18 | 8-K | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | 8-K | View |
| 2025-07-31 | 8-K | View |
| 2025-07-25 | 8-K | View |
| 2025-07-23 | 8-K | View |
| 2025-07-22 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-07-03 | EFFECT | View |
| 2025-07-03 | EFFECT | View |
| 2025-06-27 | POS AM | View |
| 2025-06-27 | POS AM | View |
| 2025-06-02 | ARS | View |
Latest News on BIAF